DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients
NCT00107614
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class
Stopped
Terminated due to poor accrual.
Conditions
Waldenstrom Macroglobulinemia
Interventions
DRUG:
DT PACE + Rituxan
Sponsor
University of Arkansas